LUPIN
Back to Cashflow Statement
|
LUPIN Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-2,184 Cr | ₹-337 Cr | ₹-1,572 Cr | ₹-1,885 Cr | ₹-891 Cr |
What is the latest Cash Flow from Financing Activities ratio of LUPIN ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-2,184 Cr |
Mar2023 | ₹-337 Cr |
Mar2022 | ₹-1,572 Cr |
Mar2021 | ₹-1,885 Cr |
Mar2020 | ₹-891 Cr |
How is Cash Flow from Financing Activities of LUPIN Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-2,184 Cr | Negative | |
Mar2023 | ₹-337 Cr | Negative | |
Mar2022 | ₹-1,572 Cr | Negative | |
Mar2021 | ₹-1,885 Cr | Negative | |
Mar2020 | ₹-891 Cr | - |
Compare Cash Flow from Financing Activities of peers of LUPIN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LUPIN | ₹91,821.8 Cr | 0.2% | -2.8% | 23.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,420.0 Cr | -0.2% | -2.9% | 12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,572.0 Cr | 0.3% | 6.5% | 49% | Stock Analytics | |
CIPLA | ₹123,329.0 Cr | 1.1% | 1.8% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,396.0 Cr | -0.2% | 9.5% | 12.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,956.0 Cr | 1.9% | 0.4% | 14% | Stock Analytics |
LUPIN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LUPIN | 0.2% |
-2.8% |
23.9% |
SENSEX | -0.8% |
-0.9% |
6.9% |
You may also like the below Video Courses